DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Air Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Type and Application” report has been added to ResearchAndMarkets.com’s offering. The air treatment market in Asia Pacific is expected to grow from US$1,964.85 million in 2021 to US$2,822.13 million by 2028; it is estimated to register a CAGR … [Read more…]

— Immune responses observed in endometrial cancer and glioblastoma models, complementing prior clinical success in glioblastoma and supporting further development of IEC-001 for the treatment of endometrial cancer — — Data further elucidates foundational anti-tumor mechanisms of the company’s immunotherapeutic platform — PHILADELPHIA–(BUSINESS WIRE)–Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, is … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Patient At Home Testing Kits Market, By Test Type, By Sample, By Usage, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Saudi Arabia patient at home testing kits market is anticipated to grow at a robust CAGR in the forecast period, 2023-2027. … [Read more…]

For the first half of 2022 turnover was €0.5 million and cash and cash equivalents were €38.4 million as of June 30, 2022 Significant milestones achieved in clinical and cGMP manufacturing programs over first half of 2022: Initiation of pivotal open-label, single-arm, Phase 3 trial of MaaT013 in acute Graft-vs-host-Disease in Europe in Q1 2022 … [Read more…]

EWING, N.J.–(BUSINESS WIRE)–Church & Dwight Co., Inc. (NYSE: CHD) will host a conference call to discuss third quarter 2022 earnings results on October 28, 2022, at 10:00 a.m. ET. Media and investors may access the live audio webcast at www.churchdwight.com beginning at 10:00 a.m. ET. The webcast will also be available for replay. Church & … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Australia Regenerative Medicine Market, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Australia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure … [Read more…]

Extending deep learning-based AIR Recon DL compatibility to 3D & PROPELLER has the potential to enable more confident patient diagnoses in MRI CHICAGO–(BUSINESS WIRE)–GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences1. The benefits of AIR Recon DL are extended by these new features to … [Read more…]

Consultation and resources available at no cost to local community FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential consultation services are offered at no charge … [Read more…]

First commercially available product to utilize AstreAdept, Astrea Bioseparations’ novel nanofiber-based membrane material CAMBRIDGE, England–(BUSINESS WIRE)–Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology. Incorporating AstreAdept™, the Company’s proprietary nanofiber … [Read more…]

The partnership* illustrates Cerba HealthCare’s strategy to support long term health response locally and increase patient access to a broader range of laboratory testing across the continent International Clinical Laboratories (ICL) will leverage the world-class expertise range of Cerba HealthCare and its existing pan-African network Cerba Lancet Africa to sustainably meet the diagnostic tool expectations … [Read more…]